Covid-19 roundup: Emergent's error costs J&J a vaccine batch; Pfizer head says EU restrictions slow vaccine distribution process
J&J has run into a snag in production of its Covid-19 vaccine after its quality patrol spotted problems with one batch of drug substance. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
